James I. Freeman is Director at DILLARDS INC (DDS). They have made 7 open-market trades across 1 company since 2012, most recently 2026-05-28.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DDS | 74,611 | $49.6M |
Shares reported on the most recent Form 4, priced at the 2026-06-01 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DDS | SELL | 2021-05-24 | 2021-05-26 | $132.57 | $5.0M | +30.1% | +37.4% | +55.6% |
| DDS | SELL | 2021-05-20 | 2021-05-24 | $130.55 | $4.7M | +21.4% | +35.4% | +52.7% |
| DDS | SELL | 2021-05-18 | 2021-05-20 | $137.63 | $4.4M | +23.9% | +24.0% | +48.1% |
| DDS | SELL | 2018-06-05 | 2018-06-07 | $93.08 | $3.5M | -1.2% | -4.1% | -18.0% |
| DDS | SELL | 2018-05-30 | 2018-06-01 | $83.02 | $1.7M | +10.1% | +10.4% | -7.3% |
| DDS | SELL | 2018-05-22 | 2018-05-24 | $75.55 | $10.4M | +16.8% | +17.1% | -1.9% |
| DDS | SELL | 2018-03-13 | 2018-03-15 | $84.05 | $1.4M | -4.9% | -6.2% | +14.5% |
| DDS | SELL · 10b5-1 | 2012-12-31 | 2013-01-02 | $84.15 | $1.2M | -5.1% | +1.3% | +1.3% |
| DDS | SELL · 10b5-1 | 2012-12-18 | 2012-12-20 | $84.27 | $6.3M | -5.1% | +1.3% | +1.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.